Medical Marijuana, Inc., the parent company of Kannaway and other innovative hemp-based companies, has announced that it once again set company sales revenue records in Q3.
Medical Marijuana, Inc.’s Q3 2018 revenue exceeded $16.8 million dollars, an increase of more than 116% over Q3 2017. Gross profit for Q3 2018 increased nearly 140% over Q3 2017. This announcement continues on a trend of successful growth for Medical Marijuana, Inc. and its portfolio of companies, including Kannaway.
Gross profit for the company for the nine-months ending September 30, 2018 increased nearly 140% over the prior year nine-month period. Revenue for the nine-month period ending September 30, 2018 exceeded $42.1 million dollars, an increase of 146% over the prior year nine-month period.
Kannaway contributed to Medical Marijuana, Inc.’s success in Q3 through a number of initiatives that added to our own trend of upward growth.
In preparation of our Europe Grand Opening Event in November, Kannaway hosted a series of regional events as part of our tour across Europe, hitting cities like Copenhagen, Oslo, Bremen, Milan, Rome, and more.